| Code | Name | Deposits | Targets | Ligand Type |
|---|---|---|---|---|
| PP2 | 1-tert-butyl-3-(4-chloro-phenyl)-1h-pyrazolo[3,4-d]pyri midin-4-ylamine | 1 | 1 | crystallization |
| PP1 | 1-ter-butyl-3-p-tolyl-1h-pyrazolo[3,4-d]pyrimidin-4-yla mine | 1 | 1 | crystallization |
| POP | 3 | 3 | crystallization | |
| POP | 5 | 5 | biological | |
| PO4 | 15 | 14 | other | |
| PO4 | 12 | 11 | biological | |
| PO4 | 60 | 51 | crystallization | |
| PO3 | phosphite ion | 1 | 1 | crystallization |
| PNK | (2r,4s)-2-{(r)-carboxy[(phenylacetyl)amino]methyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | 1 | 1 | biological |
| PLP | pyridoxal-5'-phosphate | 1 | 1 | other |
| PLP | pyridoxal-5'-phosphate | 4 | 2 | biological |
| PLM | palmitic acid | 2 | 1 | crystallization |
| PHD | aspartyl phosphate | 1 | 1 | modified residue |
| PGO | 3 | 1 | crystallization | |
| PGE | 2 | 2 | other | |
| PGE | 1 | 1 | biological | |
| PGE | 57 | 54 | crystallization | |
| PG6 | 1-(2-methoxy-ethoxy)-2-{2-[2-(2-methoxy-ethoxy]-ethoxy}-ethane | 1 | 1 | other |
| PG5 | 1 | 1 | other | |
| PG5 | 5 | 4 | crystallization |